Covered recipient · General Payments record
BRADLEY P EVERLY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$216,584.72
- Reported across 503 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $51,625.00 | 52 |
| Food and Beverage | $69.96 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CSL Plasma Inc. | $51,625.00 | 52 |
| Lilly USA, LLC | $40.04 | 2 |
| Novo Nordisk AS | $15.07 | 1 |
| ABBVIE INC. | $14.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (56)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.85 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103703250 | CMS |
| CSL Plasma Inc. | $1,000.00 | 01/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597743 | CMS |
| CSL Plasma Inc. | $1,000.00 | 01/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597785 | CMS |
| CSL Plasma Inc. | $1,000.00 | 01/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597745 | CMS |
| CSL Plasma Inc. | $1,000.00 | 01/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597747 | CMS |
| CSL Plasma Inc. | $1,000.00 | 01/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597787 | CMS |
| CSL Plasma Inc. | $1,000.00 | 01/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597789 | CMS |
| CSL Plasma Inc. | $1,000.00 | 02/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597749 | CMS |
| CSL Plasma Inc. | $1,000.00 | 02/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597791 | CMS |
| CSL Plasma Inc. | $1,000.00 | 03/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597751 | CMS |
| CSL Plasma Inc. | $1,000.00 | 03/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597755 | CMS |
| CSL Plasma Inc. | $1,000.00 | 03/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597753 | CMS |
| CSL Plasma Inc. | $1,000.00 | 03/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597793 | CMS |
| CSL Plasma Inc. | $1,000.00 | 03/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597757 | CMS |
| CSL Plasma Inc. | $1,000.00 | 04/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597759 | CMS |
| CSL Plasma Inc. | $1,000.00 | 04/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597761 | CMS |
| CSL Plasma Inc. | $1,000.00 | 04/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597763 | CMS |
| CSL Plasma Inc. | $1,000.00 | 04/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597765 | CMS |
| CSL Plasma Inc. | $1,000.00 | 04/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597795 | CMS |
| CSL Plasma Inc. | $1,000.00 | 05/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597767 | CMS |
| CSL Plasma Inc. | $1,000.00 | 05/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597797 | CMS |
| CSL Plasma Inc. | $1,000.00 | 05/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597769 | CMS |
| CSL Plasma Inc. | $1,125.00 | 05/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597771 | CMS |
| CSL Plasma Inc. | $1,000.00 | 06/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597773 | CMS |
| CSL Plasma Inc. | $1,000.00 | 06/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597799 | CMS |
| CSL Plasma Inc. | $1,000.00 | 06/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597775 | CMS |
| CSL Plasma Inc. | $1,000.00 | 06/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134597801 | CMS |
| CSL Plasma Inc. | $1,000.00 | 07/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130371 | CMS |
| CSL Plasma Inc. | $1,000.00 | 07/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130373 | CMS |
| CSL Plasma Inc. | $1,000.00 | 07/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130375 | CMS |
| CSL Plasma Inc. | $1,000.00 | 07/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130377 | CMS |
| CSL Plasma Inc. | $1,000.00 | 07/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130379 | CMS |
| CSL Plasma Inc. | $1,000.00 | 08/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130381 | CMS |
| CSL Plasma Inc. | $750.00 | 08/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130383 | CMS |
| CSL Plasma Inc. | $1,000.00 | 08/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130385 | CMS |
| CSL Plasma Inc. | $750.00 | 08/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130409 | CMS |
| CSL Plasma Inc. | $1,000.00 | 08/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130411 | CMS |
| CSL Plasma Inc. | $1,000.00 | 09/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130387 | CMS |
| CSL Plasma Inc. | $1,000.00 | 09/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130405 | CMS |
| CSL Plasma Inc. | $1,000.00 | 09/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130389 | CMS |
| CSL Plasma Inc. | $1,000.00 | 09/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130407 | CMS |
| CSL Plasma Inc. | $1,000.00 | 10/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130391 | CMS |
| CSL Plasma Inc. | $1,000.00 | 10/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130393 | CMS |
| CSL Plasma Inc. | $1,000.00 | 10/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130413 | CMS |
| CSL Plasma Inc. | $1,000.00 | 11/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130395 | CMS |
| CSL Plasma Inc. | $1,000.00 | 11/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130415 | CMS |
| CSL Plasma Inc. | $1,000.00 | 11/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130397 | CMS |
| CSL Plasma Inc. | $1,000.00 | 11/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130417 | CMS |
| CSL Plasma Inc. | $1,000.00 | 11/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130399 | CMS |
| CSL Plasma Inc. | $1,000.00 | 12/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130401 | CMS |
| CSL Plasma Inc. | $1,000.00 | 12/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130419 | CMS |
| CSL Plasma Inc. | $1,000.00 | 12/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130403 | CMS |
| CSL Plasma Inc. | $1,000.00 | 12/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130421 | CMS |
| Lilly USA, LLC | $16.87 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136068838 | CMS |
| Lilly USA, LLC | $23.17 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136068840 | CMS |
| Novo Nordisk Inc | $15.07 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097265977 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.